153 related articles for article (PubMed ID: 32184180)
1. Ondansetron buccal administration for paediatric use: A comparison between films and wafers.
Giordani B; Abruzzo A; Prata C; Nicoletta FP; Dalena F; Cerchiara T; Luppi B; Bigucci F
Int J Pharm; 2020 Apr; 580():119228. PubMed ID: 32184180
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesive Buccal Tablets Based on Chitosan/Gelatin Microparticles for Delivery of Propranolol Hydrochloride.
Abruzzo A; Cerchiara T; Bigucci F; Gallucci MC; Luppi B
J Pharm Sci; 2015 Dec; 104(12):4365-4372. PubMed ID: 26505621
[TBL] [Abstract][Full Text] [Related]
3. Design and evaluation of buccal films as paediatric dosage form for transmucosal delivery of ondansetron.
Trastullo R; Abruzzo A; Saladini B; Gallucci MC; Cerchiara T; Luppi B; Bigucci F
Eur J Pharm Biopharm; 2016 Aug; 105():115-21. PubMed ID: 27267732
[TBL] [Abstract][Full Text] [Related]
4. Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis.
Park DM; Song YK; Jee JP; Kim HT; Kim CK
Drug Dev Ind Pharm; 2012 Sep; 38(9):1077-83. PubMed ID: 22182584
[TBL] [Abstract][Full Text] [Related]
5. Freeze-Dried Matrices for Buccal Administration of Propranolol in Children: Physico-Chemical and Functional Characterization.
Abruzzo A; Crispini A; Prata C; Adduci R; Nicoletta FP; Dalena F; Cerchiara T; Luppi B; Bigucci F
J Pharm Sci; 2021 Apr; 110(4):1676-1686. PubMed ID: 33164786
[TBL] [Abstract][Full Text] [Related]
6. Bilayered buccal films as child-appropriate dosage form for systemic administration of propranolol.
Abruzzo A; Nicoletta FP; Dalena F; Cerchiara T; Luppi B; Bigucci F
Int J Pharm; 2017 Oct; 531(1):257-265. PubMed ID: 28811117
[TBL] [Abstract][Full Text] [Related]
7. Water-soluble chitosan eases development of mucoadhesive buccal films and wafers for children.
Korelc K; Larsen BS; Gašperlin M; Tho I
Int J Pharm; 2023 Jan; 631():122544. PubMed ID: 36572261
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of laminated thiolated chitosan-based freeze-dried wafers for potential buccal delivery of macromolecules.
Boateng JS; Ayensu I
Drug Dev Ind Pharm; 2014 May; 40(5):611-8. PubMed ID: 24506457
[TBL] [Abstract][Full Text] [Related]
9. Freeze-Dried Matrices Based on Polyanion Polymers for Chlorhexidine Local Release in the Buccal and Vaginal Cavities.
Giordani B; Abruzzo A; Musazzi UM; Cilurzo F; Nicoletta FP; Dalena F; Parolin C; Vitali B; Cerchiara T; Luppi B; Bigucci F
J Pharm Sci; 2019 Jul; 108(7):2447-2457. PubMed ID: 30853513
[TBL] [Abstract][Full Text] [Related]
10. Unidirectional drug release from 3D printed mucoadhesive buccal films using FDM technology: In vitro and ex vivo evaluation.
Eleftheriadis GK; Ritzoulis C; Bouropoulos N; Tzetzis D; Andreadis DA; Boetker J; Rantanen J; Fatouros DG
Eur J Pharm Biopharm; 2019 Nov; 144():180-192. PubMed ID: 31550525
[TBL] [Abstract][Full Text] [Related]
11. Localized drug delivery with mono and bilayered mucoadhesive films and wafers for oral mucosal infections.
Timur SS; Yüksel S; Akca G; Şenel S
Int J Pharm; 2019 Mar; 559():102-112. PubMed ID: 30682450
[TBL] [Abstract][Full Text] [Related]
12. Design and In Vitro/In Vivo Evaluation of Ultra-Thin Mucoadhesive Buccal Film Containing Fluticasone Propionate.
Ammar HO; Ghorab MM; Mahmoud AA; Shahin HI
AAPS PharmSciTech; 2017 Jan; 18(1):93-103. PubMed ID: 26883262
[TBL] [Abstract][Full Text] [Related]
13. Development of Tizanidine HCl-Meloxicam loaded mucoadhesive buccal films: In-vitro and in-vivo evaluation.
Zaman M; Hanif M; Shaheryar ZA
PLoS One; 2018; 13(3):e0194410. PubMed ID: 29566073
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of buccal bioadhesive tablet of an anti-emetic agent ondansetron.
Hassan N; Khar RK; Ali M; Ali J
AAPS PharmSciTech; 2009; 10(4):1085-92. PubMed ID: 19757080
[TBL] [Abstract][Full Text] [Related]
15. Development and evaluation of novel buccoadhesive wafers of nimodipine for treatment of hypertension.
Hassan N; Ali M; Ali J
Drug Deliv; 2010 Feb; 17(2):59-67. PubMed ID: 20070241
[TBL] [Abstract][Full Text] [Related]
16. Design, development and characterization of buccal bioadhesive films of Doxepin for treatment of odontalgia.
Castán H; Ruiz MA; Clares B; Morales ME
Drug Deliv; 2015; 22(6):869-76. PubMed ID: 24670096
[TBL] [Abstract][Full Text] [Related]
17. Development of buccal film formulations and their mucoadhesive performance in biomimetic models.
Göbel A; da Silva JB; Cook M; Breitkreutz J
Int J Pharm; 2021 Dec; 610():121233. PubMed ID: 34710543
[TBL] [Abstract][Full Text] [Related]
18. Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid.
Rossi S; Sandri G; Ferrari F; Bonferoni MC; Caramella C
Pharm Dev Technol; 2003; 8(2):199-208. PubMed ID: 12760570
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro release characteristics of mucosal freeze-dried wafers and solvent-cast films containing an insoluble drug.
Boateng JS; Matthews KH; Auffret AD; Humphrey MJ; Eccleston GM; Stevens HN
Drug Dev Ind Pharm; 2012 Jan; 38(1):47-54. PubMed ID: 21714725
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces.
Boateng JS; Auffret AD; Matthews KH; Humphrey MJ; Stevens HN; Eccleston GM
Int J Pharm; 2010 Apr; 389(1-2):24-31. PubMed ID: 20083177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
